Current Drug Shortages

This page contains up-to-date information on current shortages of medically necessary veterinary products.

When drug shortages involve medically necessary veterinary products, it is FDA’s policy to help prevent or alleviate them. FDA works with drug manufacturers in the U.S. and, when necessary, other countries, to find ways to resolve these shortages. FDA does not have the authority to require a company to make any product, even if it is medically necessary.

Posting Date	Product	Company Information	Reason
8/23/2019	Oxytetracycline Injection 200 mg/ml	Norbrook Laboratories	Manufacturing delay
8/23/2019	Oxytetracycline 100 mg/ml	Norbrook Laboratories	Manufacturing delay
8/23/2019	Flunixin Meglumine Injection	Norbrook Laboratories	Manufacturing delay
8/23/2019	Flunixin Injection-S	Norbrook Laboratories	Manufacturing delay
8/23/2019	Ivermectin + Clorsulon	Norbrook Laboratories	Manufacturing delay.  A recently approval of a product with the same ingredient is available to the market.  Demand increase still requires monitoring to assure adequate supply.
8/23/2019	Meloxican (injectable)	Norbrook Laboratories	Manufacturing delay
8/23/2019	Meloxican (injectable)	Norbrook Laboratories	Manufacturing delay
10/17/2017	Pentobarbital Sodium + Phenytoin Sodium	Various companies	Manufacturing delay
10/17/2017	Poloxalene Liquid Type A Medicated Article	Phibro Animal Health Corp.	Manufacturing delay
08/08/2016	Chloramine-T	Axcentive SARL	Manufacturing delay
4/13/2015	IV Fluids for Animal Use, 3L & 5L volume size	Various companies	Demand Increase, Reduction in the manufacturing of 3L & 5L volume size
11/28/2011	Atropine Sulfate	Sparhawk Laboratories, Inc. http://www.sparhawklabs.com Customer Service – 800-255-6368	Discontinued distribution.
11/10/2010	Epinephrine 1 mg/mL	RVX distributed by Teva http://www.tevapharm.com	Discontinued distribution. Approved human product available in adequate supply, 30 ml vials.

Information about Resolved Drug Shortages